Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation
Stopped early · Phase 3
Conditions studied: Paroxysmal Atrial Fibrillation
In brief
This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.
Key facts
- Study ID
- NCT00741611
- Run by
- C. R. Bard
- People needed
- 44
- Starts
- 2008-07-01
- Expected to finish
- 2009-11-01
- Last updated by the study team
- 2012-10-26
Who can join
Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with symptomatic paroxysmal atrial fibrillation who have failed at least one class I or III anti-arrhythmic drug
- Other inclusion criteria
You may not qualify if…
- Previous surgical or catheter ablation to treat AF
- Permanent AF
- Uncontrolled or unstable medical conditions
- Other exclusion criteria
Where it is running
- University of California, San Diego Medical Center — San Diego, California, United States
- Aurora Denver Cardiology Associates — Aurora, Colorado, United States
- University of Florida — Gainesville, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Florida Heart Group — Orlando, Florida, United States
- Bay Heart Group — Tampa, Florida, United States
- Piedmont Hospital Research Institute — Atlanta, Georgia, United States
- Northeast Cardiology Associates — Bangor, Maine, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Caritas St. Elizabeth's Medical Center — Boston, Massachusetts, United States
- St. John's Medical Research Institute — Springfield, Missouri, United States
- Lehigh Valley Heart Specialists — Allentown, Pennsylvania, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.